Australia Women's Health Market Size & Outlook, 2024-2030
Australia women's health market, 2018-2030 (US$M)
Related Markets
According to the Fertility Society of Australia and New Zealand, every sixth couple has trouble becoming pregnant. Problems with fertility can be brought on by illnesses and other conditions. Overall, female reproductive difficulties account for one-third of infertility cases.
Such factors are expected to boost market growth. Moreover, players in the country are adopting various strategies to expand their market presence and meet consumer demand. For instance, in July 2022, Mayne Pharma Group Limited and Mithra Pharmaceuticals, SA announced the availability of NEXTSTELLIS, an oral contraceptive with a novel estrogen in Australia.
Similarly, in October 2021, Slinda, a contraceptive pill manufactured by Exeltis, became available in Australia. Moreover, favorable initiatives undertaken by government bodies to consume contraceptive pills are expected to drive the market.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Women's Health Market Scope
Women's Health Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Australia Women's Health Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
